Nektar Therapeutics (NKTR) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Nektar Therapeutics

    NASDAQ: NKTR · Real-Time Price · USD
    40.18
    4.20 (11.67%)
    At close: Sep 05, 2025, 3:59 PM
    40.40
    0.55%
    After-hours: Sep 05, 2025, 07:36 PM EDT

    Nektar Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 44.25M 35.28M 88.23M 25.22M
    Short-Term Investments
    		 210.97M 268.34M 416.75M 708.74M
    Long-Term Investments
    		 26.09M 25.82M n/a 64.83M
    Other Long-Term Assets
    		 4.65M 4.64M 2.25M 2.74M
    Receivables
    		 1.61M 2.25M 5.98M 22.49M
    Inventory
    		 n/a 16.1M 19.2M 15.8M
    Other Current Assets
    		 n/a n/a 2.42M n/a
    Total Current Assets
    		 261.29M 330.7M 545.97M 795.58M
    Property-Plant & Equipment
    		 11.82M 36.86M 85.89M 177.53M
    Goodwill & Intangibles
    		 n/a n/a 76.5M 76.5M
    Total Long-Term Assets
    		 42.56M 67.33M 164.63M 321.61M
    Total Assets
    		 303.85M 398.03M 710.6M 1.12B
    Account Payables
    		 11.56M 9.85M 12.98M 9.75M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a 19.26M 18.67M 17.44M
    Other Current Liabilities
    		 29.97M -2.65M 8.31M 24.84M
    Total Current Liabilities
    		 61.4M 51.27M 68.2M 85.2M
    Long-Term Debt
    		 91.78M 112.63M 126.47M 148.11M
    Other Long-Term Liabilities
    		 7.24M 4.63M 36.46M 78.63M
    Total Long-Term Liabilities
    		 181.71M 215.78M 275.76M 352.48M
    Total Liabilities
    		 243.11M 267.05M 343.96M 437.68M
    Total Debt
    		 102.56M 117.78M 131.5M 143.18M
    Common Stock
    		 19K 19K 19K 19K
    Retained Earnings
    		 -3.6B -3.48B -3.2B -2.83B
    Comprehensive Income
    		 61K 80K -6.91M -4.16M
    Shareholders Equity
    		 60.74M 130.99M 366.64M 679.51M
    Total Investments
    		 237.06M 294.16M 416.75M 773.57M

    Add to Watchlist